美国、日本_、印度、中国医药股历史估值背后的逻辑试究.pptVIP

Goldman Sachs Global Investment Research * Wei Du, PhD Gao Hua Securities 86-21-2401-8928 wei.du@ Li Yu Gao Hua Securities 86-21-2401-8932 li.yu@ 美国、日本 、印度、中国医药股历史估值背后的逻辑试究用全球化视角研判中国医药股估值合理性 July 2010 Coverage view: Neutral The Goldman Sachs Group, Inc. does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Inve